Ahmed S. Goolam

Chris O’Brien Lifehouse

Papers

1

Total Citations

6

H-Index

1

About

Dr. Ahmed S. Goolam is a pioneering urologic surgeon whose work centers on advancing minimally invasive surgical techniques for testicular cancer. His primary research focus is the refinement and validation of robotic-assisted retroperitoneal lymph node dissection (R-RPLND), a complex procedure for treating stage II testicular cancer. Dr. Goolam’s major contribution lies in demonstrating the feasibility and safety of this robotic approach through prospective clinical studies, offering patients a less invasive alternative with potentially reduced morbidity compared to traditional open surgery. His landmark 2022 paper, which has garnered 6 citations, provides critical early evidence on perioperative outcomes and oncological control, establishing a foundation for broader adoption of this technique. By systematically evaluating this novel application of robotic surgery, Dr. Goolam is helping to shape the standard of care for testicular cancer management, bridging the gap between technological innovation and tangible patient benefit. His work represents a significant step forward in urologic oncology, offering hope for improved recovery and quality of life for young men facing this diagnosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Robotic-assisted retroperitoneal lymph node dissection for stage II testicular cancer
6 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Chris O’Brien Lifehouse

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago